Adial Pharmaceuticals Inc... (ADILW)
NASDAQ: ADILW
· Real-Time Price · USD
0.00
-0.00 (-100.00%)
At close: Jul 27, 2023, 9:52 PM
Adial Pharmaceuticals WT EXP 073123 Income Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | 32.25K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | 141.00 | 141.00 | 141.00 | 141.00 | 141.00 | 15.84K | 15.55K | 15.26K | 14.98K | 14.71K | 16.39K | 12.28K | 13.97K | 12.47K |
Gross Profit | n/a | n/a | -141 | -141 | 32.1K | -141 | -141 | -15.84K | -15.55K | -15.26K | -14.98K | -14.71K | -16.39K | -12.28K | -13.97K | -12.47K |
Operating Income | -1.94M | -2.21M | -2.29M | -1.85M | -1.78M | -1.36M | -1.48M | -2.92M | -3.24M | -3.19M | -3.83M | -3.06M | -5.98M | -4.06M | -4.4M | -4.84M |
Interest Income | 53.76K | 50.69K | 51.4K | 22.8K | 11.22K | 10.24K | 19.43K | 28.89K | 47.82K | 3.47K | 6.93K | 5.12K | 2.2K | 2.86K | 1.18K | 295.00 |
Pretax Income | -2.07M | -2.19M | -2.46M | -6.48M | -1.9M | -1.35M | -1.51M | -2.91M | -2.87M | -3.11M | -3.85M | -2.91M | -5.92M | -4.32M | -4.44M | -4.83M |
Net Income | -2.07M | -2.19M | -2.46M | -6.48M | -1.92M | -1.38M | 1.09M | -2.89M | -2.87M | -3.03M | -3.86M | -2.76M | -5.83M | -4.32M | -4.44M | -4.83M |
Selling & General & Admin | 1.21M | 1.18M | 1.27M | 1.39M | 1.52M | 1.15M | 1.05M | 2.24M | 2.1M | 1.94M | 2.63M | 2.46M | 2.1M | 2.37M | 2.08M | 2.79M |
Research & Development | 730.79K | 1.03M | 1.01M | 454.28K | 264.44K | 207.13K | 429.9K | 676.43K | 1.14M | 1.24M | 1.2M | 596.34K | 2.33M | 1.69M | 2.32M | 2.05M |
Other Expenses | n/a | n/a | n/a | -42 | 51.9K | n/a | -51.9K | n/a | n/a | n/a | n/a | n/a | 1.55M | 17.41K | -67.48K | 6.28K |
Operating Expenses | 1.94M | 2.21M | 2.29M | 1.84M | 1.78M | 1.36M | 1.48M | 2.92M | 3.24M | 3.19M | 3.83M | 3.06M | 4.43M | 4.06M | 4.4M | 4.84M |
Interest Expense | n/a | n/a | n/a | n/a | 14.89K | n/a | n/a | n/a | n/a | n/a | 17.07K | n/a | 188.15K | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | -141 | -141 | 1.52M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 1.94M | 2.21M | 2.29M | 1.85M | 1.78M | 1.36M | 1.48M | 2.92M | 3.24M | 3.19M | 3.83M | 3.06M | 4.43M | 4.06M | 4.4M | 4.84M |
Income Tax Expense | n/a | n/a | n/a | -1 | 15.89K | 37.28K | -2.6M | -14.89K | -502 | -78.34K | 17.07K | -151.12K | -94.08K | 271.66K | 37.21K | -6.57K |
Shares Outstanding (Basic) | 18.59M | 5.84M | 4.18M | 2.95M | 1.66M | 1.18M | 1.13M | 1.06M | 1.07M | 1.03M | 972.64K | 926.05K | 821.14K | 793.92K | 703.55K | 636.48K |
Shares Outstanding (Diluted) | 18.59M | 5.84M | 4.18M | 2.95M | 1.66M | 1.18M | 1.13M | 1.06M | 1.07M | 1.03M | 972.64K | 926.05K | 830.44K | 793.92K | 703.55K | 636.48K |
EPS (Basic) | -0.11 | -0.38 | -0.59 | -2.19 | -1.15 | -1.18 | 0.96 | -2.73 | -2.69 | -2.95 | -3.97 | -2.98 | -7.1 | -5.44 | -6.31 | -7.59 |
EPS (Diluted) | -0.11 | -0.38 | -0.59 | -2.19 | -1.15 | -1.18 | 0.96 | -2.73 | -2.69 | -2.95 | -3.97 | -2.98 | -7.02 | -5.44 | -6.31 | -7.59 |
EBITDA | -1.94M | -2.21M | -2.29M | -1.84M | -1.9M | -1.36M | -1.48M | -2.27M | -3.09M | -2.55M | -3.24M | -3.06M | -4.38M | -4.06M | -4.39M | -4.83M |
EBIT | -1.94M | -2.21M | -2.29M | -1.85M | -1.9M | -1.36M | -1.48M | -2.27M | -3.24M | -3.11M | -3.24M | -3.06M | -4.43M | -4.06M | -4.4M | -4.84M |
Depreciation & Amortization | 141.00 | 142.00 | 141.00 | 141.00 | 141.00 | 141.00 | 141.00 | 15.84K | 15.55K | 15.26K | 14.98K | 14.71K | 16.39K | 12.28K | 13.97K | 12.47K |